Skip to main content

Edition 2024 of the Asociación Española de Hematología y Hemoterapia (SEHH) and the Sociedad Española de Trombosis y Hemostasia (SETH):

  • Oral presentation on extended results from the Early Access Program (EAP) for aGvHD patients treated with MaaT013
  • Poster on the Phoebus study: Phase 2b trial for patients receiving allo-GCSH
MaaT Pharma
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

MaaT Pharma dans les médias MaaT Pharma in the News Devenez membre du club Become a member of the club